A novel substitution in NS5A enhances the resistance of hepatitis C virus genotype 3 to daclatasvir. (2021)
Attributed to:
Hepatitis C virus genotype 3 NS5A protein: resistance to direct acting antiviral agents and functional analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1099/jgv.0.001496
PubMed Identifier: 33141008
Publication URI: http://europepmc.org/abstract/MED/33141008
Type: Journal Article/Review
Volume: 102
Parent Publication: The Journal of general virology
Issue: 1
ISSN: 0022-1317